Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 0 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2025
Thermo Fisher Scientific Brussels from Merelbeke-Melle, company number BE0797110366, closed financial year 2025 with a result of € -83,852 after tax. Compared with financial year 2024, the result moved from € -68,442 to € -83,852. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.
€ 611.6 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -83,852
▼ 23 % more loss than in 2024
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € -266,064.
Debts at end 2025
€ 223,900
▲ 55% vs 2024
Loans from banks and other lenders, long and short.
€ 22,801
▲ 24% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 113 days on average.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Profit after taxes | € -113,770 | € -68,442 | € -83,852 | ▼ € 15,410 |
| Equity | € 611,722,993 | € 611,654,551 | € 611,570,699 | |
| Total debts | € 114,140 | € 162,849 | € 246,701 | ▲ 51% |
| Cash | € 19,733 | - | - | |
| Retained profit | € -113,770 | € -182,212 | € -266,064 | ▼ € 83,852 |
| Bank debt | € 108,288 | € 144,417 | € 223,900 | ▲ 55% |
| Balance sheet total | € 611,837,133 | € 611,817,400 | € 611,817,400 |
Key figures of Thermo Fisher Scientific Brussels, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Thermo Fisher Scientific Brussels?
What happened at Thermo Fisher Scientific Brussels in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 83,852. Source: NBB ↗
- New establishment in Merelbeke-Melle. KBO
- Start of the company according to the CBE. KBO
- Petrus Thomas Adrianus VAN DER ZANDE became a director. NBB
- Anthony H. SMITH became a director. NBB
In short
From € 113,770 loss in 2023 to € 83,852 loss in 2025.
Pays suppliers within 113 days on average.
Management
Behind Thermo Fisher Scientific Brussels are Petrus Thomas Adrianus VAN DER ZANDE and Anthony H. SMITH. The shares are held by Thermo Fisher Scientific Peprotech Holding LLC (50%) and Thermo Fisher Scientific Odyssey Holding LLC (50%). It owns 100% of Henogen SRL, 100% of Thermo Fisher Scientific GCL LLC and 99% of PPD Global Central Labs BV itself.
Directors
According to the 2025 annual accounts
Petrus Thomas Adrianus VAN DER ZANDE
Director
since 2023
Anthony H. SMITH
Director
since 2023
Shareholders
Thermo Fisher Scientific Peprotech Holding LLC
50%
Thermo Fisher Scientific Odyssey Holding LLC
50%
Participations
Establishments
Establishment units
Physical locations of this company
Guldensporenpark 52
9820 Merelbeke-Melle
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0797.110.366
- VAT number
- BE 0797.110.366
- Registered office
- Guldensporenpark 52, 9820 Merelbeke-Melle
- Names & denominations
- Thermo Fisher Scientific Brussels
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 January 2023
- Peppol
- Active · Active since 6 Feb 2023
- Activities · NACE
Handel in eigen onroerend goed